- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT07603934
The Effect of Different Intra-canal Medications on Postoperative Pain
Evaluation of Postoperative Pain After Using Ibuprofen, Nitrofurantoin, or Calcium Hydroxide as Intracanal Medicaments in Root Canal Treatment of Necrotic Mandibular Posterior Teeth. A Randomized Controlled Trial
The aim of this study is to assess the effect of ibuprofen, nitrofurantoin, and calcium hydroxide on postoperative pain after endodontic treatment of necrotic mandibular posterior teeth
Research question/hypothesis:
In patients with necrotic pulps in their mandibular posterior teeth, there would be no difference in the incidence and/or severity of postoperative pain after the use of ibuprofen, nitrofurantoin, or calcium hydroxide intracanal medications.
The study will evaluate postoperative pain after using either of the tested drugs as an intracanal medication amidst visits. of endodontic treatment in cases where pulp necrosis is confirmed.
Descripción general del estudio
Estado
Condiciones
Intervención / Tratamiento
Descripción detallada
Trial design:
- A Randomized controlled, double-blind, parallel-arm, clinical trial.
- Allocation ratio 1:1:1
- Framework: superiority
- Study settings:
Outpatient clinic of Endodontics at the Faculty of Dentistry, Egyptian Russian University, Badr city, Cairo governorate, Egypt.
Eligibility criteria
Inclusion criteria:
- Patients with necrotic pulps.
- Adult, healthy patients, older than 18 years old
- Males and females.
- Patient with the ability to understand and use pain scales.
- Patient who accepts enroll to the study.
Exclusion criteria:
- Patients' allergies or any other contraindication to any of the medications used.
- Pregnant and lactating females.
- Patients have been taking pain medication 12 hours earlier.
- Patients who have more than one symptomatic mandibular tooth in the same quadrant.
- Patients with contributory medical history (ASA>II).
- Diagnosis:
The diagnosis of pulp necrosis is confirmed through the patients' history, lack of response to cold testing and negative response to electric pulp tester whenever .The treatment will be done on two- visits.
• Treatment procedure: Each patient will be given an NRS chart to rate her /his presenting pain as preoperative pain. After complete mechanical preparation, each patient will be randomly assigned to either of three groups as follows, group 1: ibuprofen will be used as an intracanal medication, group 2: nitrofurantoin will be used as an intra canal medication and group 3: CaOH will be used as an intracanal medicament. The access cavity will be then sealed with temporary filling (MD-TEMP, META BIOMED CO., LTD. Chungbuuk, Korea). Post-operative instructions and appropriate post-operative rescue medication will be prescribed (400mg Ibuprofen). All patients will be asked to record their postoperative pain level felt on NRS at 6, 12, 24, 48, 72 hours and 7 days.
One week after the first visit, patients will be recalled to the clinic to complete their root canal treatment as recommended. All canals will be dried then obturated by the modified single cone technique using 0.04 taper gutta percha points and epoxy resin sealer. Patients will be referred to an operative or a fixed prosthodontics specialist for crown placement at the Faculty of Dentistry, Egyptian Russian University.
Research objective (state the aim) The aim of this study is to assess the effect of ibuprofen, nitrofurantoin and calcium hydroxide on postoperative pain after endodontic treatment of necrotic mandibular posterior teeth.
Sample size: (if calculation equation is used please state) A total of 111 patients, 37 per group needed for the clinical trial was calculated
Grouping & Randomization used:(specify if present) Three groups Group 1: ibuprofen Group 2: nitrofurantoin Group 3: calcium hydroxide
Outcome variables:
The primary outcome the effect of ibuprofen, nitrofurantoin and calcium hydroxide on postoperative pain after endodontic treatment of necrotic mandibular posterior teeth.
Postoperative pain will be measured using NRS at 6, 12, 24, 48, 72 hours postoperatively. Numerical Rating Scale (NRS) (20): It is an 11-point scale consisting of numbers from 0 through 10; - 0 reading represents "no pain" - 1-3 readings represent "mild pain" - 4- 6 readings represent "moderate pain" - 7- 10 readings represent "severe pain"
Tipo de estudio
Inscripción (Estimado)
Fase
- Fase temprana 1
Contactos y Ubicaciones
Ubicaciones de estudio
-
-
Cairo Governorate
-
Cairo, Cairo Governorate, Egipto, 4450113
- Reclutamiento
- Faculty of Oral and Dental Medicine, Egyptian Russian University
-
Contacto:
- Correo electrónico: maha-nasrmorsi@eru.edu.eg
-
Investigador principal:
- Maha Nasr, Assistant Professor
-
Contacto:
- Maha Nasr, Assistant professor
- Número de teléfono: 01114367063
- Correo electrónico: mahmouhaa87@gmail.com
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
- Adulto
Acepta Voluntarios Saludables
Descripción
Inclusion Criteria:
- Patients with necrotic pulps.
- Adult, healthy patients, older than 18 years old
- Males and females.
- Patient with the ability to understand and use pain scales.
- Patient who accepts enroll to the study.
Exclusion Criteria:
- Patients' allergies or any other contraindication to any of the medications used.
- Pregnant and lactating females.
- Patients have been taking pain medication 12 hours earlier.
- Patients who have more than one symptomatic mandibular tooth in the same quadrant.
- Patients with contributory medical history (ASA>II).
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Tratamiento
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Doble
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Experimental: ibuprofen
Ibuprofen.
a NSAID, will be ground and formed into a paste to be placed inside the root canals of necrotic mandibular posterior teeth, to explore its effects on post-operative pain
|
Ibuprofen.
a NSAID, will be ground and formed into a paste to be placed inside the root canals of necrotic mandibular posterior teeth, to explore its effects on post-operative pain
|
|
Experimental: nitrofurantoin
|
Nitrofurantoin tablets will be formed into a paste to be placed inside the root canals of necrotic mandibular premolars during endodontic treatment.
|
|
Comparador activo: calcium hydroxide
|
Calcium Hydroxide intracanal medicament will be placed inside the root canals of mandibular necrotic posterior teeth during endodontic treatment.
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Intensity of Postoperative pain
Periodo de tiempo: Baseline (preoperative) and at 6, 12, 24, 48 and 72 hours after placement of the intracanal medicament.
|
Postoperative pain intensity will be self-reported by patients using an 11-point Numerical rating scale (NRS), where 0 represents "no paon" and 10 represents "the worst immaginable pain"
|
Baseline (preoperative) and at 6, 12, 24, 48 and 72 hours after placement of the intracanal medicament.
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Incidence of Postoperative pain
Periodo de tiempo: Up to 72 hours after placement of intracanal medicament
|
The percentage of patients experiencing any postoperative pain (NRS=0) within the follow-up period
|
Up to 72 hours after placement of intracanal medicament
|
|
Postoperative Analgesic Consumption
Periodo de tiempo: Up to 72 hours postoperatively
|
The total amount of prescribed analgesics consumed by the oatient.
this will be measured by counting the total number of Ibuprofen 400 mg tablets taken by patients.
|
Up to 72 hours postoperatively
|
Colaboradores e Investigadores
Patrocinador
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Actual)
Finalización primaria (Estimado)
Finalización del estudio (Estimado)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
Términos MeSH relevantes adicionales
- Enfermedades periodontales
- Enfermedades de la Boca
- Enfermedades Estomatognáticas
- Procesos Patológicos
- Enfermedades periapicales
- Enfermedades de la mandíbula
- Enfermedades de la pulpa dental
- Enfermedades de los dientes
- Necrosis
- Periodontitis
- Condiciones Patológicas, Signos y Síntomas
- Periodontitis periapical
- Necrosis de la pulpa dental
- Químicos orgánicos
- Compuestos heterocíclicos, 1 anillo
- Compuestos heterocíclicos
- Ácidos carboxílicos
- Químicos inorgánicos
- Aniones
- Iones
- Electrolitos
- Hidróxidos
- Álcalies
- Ácidos, carbocíclicos
- Compuestos nitro
- Fenilpropionatos
- Compuestos de calcio
- Furanos
- Nitrofuranos
- Ibuprofeno
- Nitrofurantoína
- Hidróxido de calcio
Otros números de identificación del estudio
- ERU2
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
producto fabricado y exportado desde los EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .